A Prospective, Single-Arm, Phase 2 Study of Modified Transarterial Chemoembolization Using Low-Dose Chemotherapy with Blank Microspheres Plus Low-Dose Lenvatinib and Microwave Ablation in Patients with Large (≥7 cm) Unresectable Hepatocellular Carcinoma: The TALEM Trial

A Prospective, Single-Arm, Phase 2 Study of Modified Transarterial Chemoembolization Using Low-Dose Chemotherapy with Blank Microspheres Plus Low-Dose Lenvatinib and Microwave Ablation in Patients with Large (≥7 cm) Unresectable Hepatocellular Carcinoma: The TALEM Trial

Introduction: For patients with large unresectable hepatocellular carcinoma (HCC), the effectiveness of conventional transarterial chemoembolization (cTACE) remains suboptimal. This study investigated the efficacy and safety of modified TACE using low-dose chemotherapy with blank microspheres (BMS-T...

Full description

Bibliographic Details
Main Authors: Zhi-Mei Huang, Xue Han, Jian Wang, Ling Gu, Lu Tang, Shao-Yong Wu, Tian Di, Ying-Wen Hou, Wan Yee Lau, Yi-Quan Jiang, Jin-Hua Huang
Format: Article
Language:English
Published: Karger Publishers 2024-01-01
Series:Liver Cancer
Subjects:
blank microsphere transarterial chemoembolization
large unresectable hepatocellular carcinoma
levatinib
Online Access:https://beta.karger.com/Article/FullText/536518

Internet

https://beta.karger.com/Article/FullText/536518

Similar Items